Comparing two treatments for a common eye surface condition
Part of Eyes & vision clinical trials.
This study compares two ways to treat a condition that affects the clear front part of the eye (the cornea), causing symptoms like eye pain and blurry vision. The goal is to see which treatment works better and is safer for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be able to give informed consent (agree to participate after understanding the study).
- You must be able to attend follow-up appointments for at least 1 year after treatment.
- You must have symptoms from the condition in both eyes, such as repeat episodes of eye pain (like a scratchy feeling) or blurry vision.
- You must be eligible for surgery on both eyes.
- You must not have a history of eye infection caused by the herpes simplex virus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This trial compares two types of cornea transplant surgery (PKP and DSAEK) to see which one helps people with severe corneal swelling see better after two years. It may be an option if you have advanced bullous keratopathy and need a first-time cornea transplant.
This study looks at people with diseases of the eye surface (the clear front part of the eye) to find out which factors predict how well their vision will be after treatment. By joining, you help researchers learn more about these conditions and what may affect visual recovery.
This trial looks at how to manage medicine around DMEK corneal transplant surgery to improve eye outcomes and safety. It may help people having this specific type of cornea transplant by testing an approach in the time after surgery.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
Hear when a new Epithelial Basement Membrane Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.